These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2808794)
41. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin]. Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095 [TBL] [Abstract][Full Text] [Related]
42. [Nail hyperpigmentation as a secondary effect of doxorubicin]. Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110 [No Abstract] [Full Text] [Related]
43. Hyperpigmentation of the nail from lead deposition. Zhu WY; Xia MY; Huang SD; Du D Int J Dermatol; 1989 May; 28(4):273-5. PubMed ID: 2722344 [No Abstract] [Full Text] [Related]
44. Nail hyperpigmentation secondary to therapy with doxorubicin. Giacobetti R; Esterly NB; Morgan ER Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789 [TBL] [Abstract][Full Text] [Related]
45. Nail pigmentation following cancer chemotherapy. A new genetic entity? Sulis E; Floris C Eur J Cancer (1965); 1980 Nov; 16(11):1517-9. PubMed ID: 6453014 [No Abstract] [Full Text] [Related]
47. Nail, skin, and scleral pigmentation induced by minocycline. Angeloni VL; Salasche SJ; Ortiz R Cutis; 1987 Sep; 40(3):229-33. PubMed ID: 3652731 [TBL] [Abstract][Full Text] [Related]
48. Nail discoloration occurring after 8 weeks of minocycline therapy. Ban M; Kitajima Y J Dermatol; 2007 Oct; 34(10):699-701. PubMed ID: 17908141 [TBL] [Abstract][Full Text] [Related]